- Trials with a EudraCT protocol (166)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
166 result(s) found for: Depressive anxiety.
Displaying page 1 of 9.
EudraCT Number: 2005-001606-66 | Sponsor Protocol Number: OLZvsLMT-DB | Start Date*: 2005-06-16 | |||||||||||
Sponsor Name:AZIENDA SANITARIA OSPEDALIERA "S. GIOVANNI BATTISTA DI TORINO" | |||||||||||||
Full Title: OLANZAPINE VS LAMOTRIGINE ADD-ON TO LITHIUM:EFFICACY ON ANXIETY SYMPTOMS IN REMITTING BIPOLAR PATIENTS | |||||||||||||
Medical condition: EFFICACY ON ANXIETY SYMPTOMS IN REMITTING BIPOLAR PATIENTS | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-000426-62 | Sponsor Protocol Number: CHDR1203-E | Start Date*: 2013-04-10 | ||||||||||||||||
Sponsor Name:Centre for Human Drug Research | ||||||||||||||||||
Full Title: A randomized, double blind, placebo-controlled crossover study to investigate the effects of a selective serotonergic reuptake inhibitor on resting state fMRI in healthy volunteers. | ||||||||||||||||||
Medical condition: healthy volunteers 'depression, anxiety' | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-003404-12 | Sponsor Protocol Number: CL2-20098-075 | Start Date*: 2013-02-12 | ||||||||||||||||
Sponsor Name:Institut de Recherches Internationales Servier | ||||||||||||||||||
Full Title: Pharmacokinetics and safety of agomelatine in children (from 7 to less than 12 years) and adolescents (from 12 to less than 18 years) with Depressive or Anxiety Disorder. An open-labelled, multice... | ||||||||||||||||||
Medical condition: Depressive or Anxiety Disorder | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: FI (Completed) SE (Completed) HU (Completed) EE (Completed) RO (Completed) PL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-020170-42 | Sponsor Protocol Number: 12708A | Start Date*: 2012-10-05 | ||||||||||||||||
Sponsor Name:H. Lundbeck A/S | ||||||||||||||||||
Full Title: An open-label study evaluating the Pharmacokinetics and Tolerability of Lu AA21004 in connection with multiple oral dosing of Lu AA21004 in child and adolescent patients with a DSM-IV-TRTM diagnosi... | ||||||||||||||||||
Medical condition: DSM-IV-TRTM diagnosed Depressive or Anxiety Disorder | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-022460-12 | Sponsor Protocol Number: MVH-03 | Start Date*: 2011-03-23 | ||||||||||||||||||||||||||
Sponsor Name:Herlev Hospital | ||||||||||||||||||||||||||||
Full Title: The effect of melatonin on depression, anxiety, cogntive function and sleep disturbances in breast cancer patients | ||||||||||||||||||||||||||||
Medical condition: Depression Anxiety Postoperative cognitive dysfunction Sleep disturbances | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||||||||||||
Trial protocol: DK (Prematurely Ended) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-004006-81 | Sponsor Protocol Number: LTE5376 | Start Date*: 2006-06-01 | |||||||||||
Sponsor Name:sanofi-aventis recherche&developpement | |||||||||||||
Full Title: A double-blind, 6 to 12-month, multicenter, multinational, randomized study evaluating the efficacy and safety of SR58611A (350 mg q12) versus placebo in the prevention of relapse / recurrence of d... | |||||||||||||
Medical condition: patients with major depressive disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Completed) FI (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005597-67 | Sponsor Protocol Number: EFC4846 | Start Date*: 2006-03-29 | |||||||||||
Sponsor Name:sanofi-aventis recherche & développement | |||||||||||||
Full Title: An eight-week, double-blind placebo controlled, multicenter study evaluating the efficacy, safety, tolerability of a fixed dose of SR58611A (350 mg q12) in elderly patients with Major Depressive Di... | |||||||||||||
Medical condition: Major Depressive Disorder (MDD) | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-000465-31 | Sponsor Protocol Number: CannaBiD | Start Date*: 2016-06-29 | |||||||||||||||||||||||||||||||
Sponsor Name:Charité - Universitätsmedizin Berlin | |||||||||||||||||||||||||||||||||
Full Title: Cannabidiol in Bipolar Depression – CannaBiD-Study: An 8-week randomized, double-blind, placebo-controlled clinical trial of Cannabidiol as add-on therapy in bipolar depression | |||||||||||||||||||||||||||||||||
Medical condition: Bipolar disorder, current episode depressed | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-000438-21 | Sponsor Protocol Number: 750201.01.035 | Start Date*: 2012-10-17 | |||||||||||
Sponsor Name:Dr. Willmar Schwabe GmbH & Co. KG | |||||||||||||
Full Title: Multi-center, double-blind, placebo-controlled, randomized phase III study to prove the efficacy, safety and tolerability of Silexan (WS®1265) in patients with mixed anxiety and depressive disorder... | |||||||||||||
Medical condition: mixed anxiety and depressive disorder (ICD-10, F41.2) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002007-29 | Sponsor Protocol Number: 42165279MDD2001 | Start Date*: 2015-11-24 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: A Phase 2a Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multi-center Study Investigating the Efficacy, Safety, and Tolerability of JNJ-42165279 in Subjects with Major Depressive Di... | |||||||||||||
Medical condition: Major Depressive Disorder Anxiety | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-000370-20 | Sponsor Protocol Number: 2448/2007 | Start Date*: 2008-08-05 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA PISANA | |||||||||||||
Full Title: Evaluation of pharmacokinetic and pharmacodynamic interactions between escitalopram and drugs used for the treatment of bipolar disorders. | |||||||||||||
Medical condition: bipolar disorders | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-003658-47 | Sponsor Protocol Number: F02207 GE 3 03 | Start Date*: 2006-11-21 | |||||||||||
Sponsor Name:Pierre Fabre Médicament - IRPF | |||||||||||||
Full Title: Exploratory study of the efficacy and safety of flexible doses of Milnacipran and Venlafaxine administered in out patients with Major Depressive Disorder. | |||||||||||||
Medical condition: Major Depressive Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-001325-27 | Sponsor Protocol Number: 18314A | Start Date*: 2019-12-26 | |||||||||||
Sponsor Name:H. Lundbeck A/S | |||||||||||||
Full Title: Interventional, open-label effectiveness study of flexible doses of vortioxetine on depressive symptoms in patients with major depressive disorder comorbid with generalized anxiety disorder | |||||||||||||
Medical condition: Depressive symptoms in patients with major depressive disorder (MDD) comorbid with generalized anxiety disorder (GAD) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-006121-26 | Sponsor Protocol Number: 40411813DAX2001 | Start Date*: 2012-06-06 | |||||||||||
Sponsor Name:Janssen-Cilag International N.V. | |||||||||||||
Full Title: A Multicenter, Double-Blind, Placebo-Controlled Study of JNJ-40411813 as Adjunctive Treatment to an Antidepressant in Adults with Major Depressive Disorder with Anxiety Symptoms | |||||||||||||
Medical condition: Major Depressive Disorder with Anxiety Symptoms | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) BG (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001779-35 | Sponsor Protocol Number: 4 | Start Date*: 2013-02-15 | |||||||||||
Sponsor Name:University of Southampton | |||||||||||||
Full Title: The effects of pregabalin augmentation of antidepressant drug on neuro-cognitive functioning in patients with generalized anxiety disorder | |||||||||||||
Medical condition: Generalised anxiety disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002116-32 | Sponsor Protocol Number: MTM-04 | Start Date*: 2015-09-23 | ||||||||||||||||||||||||||
Sponsor Name:Køge Hospital | ||||||||||||||||||||||||||||
Full Title: The effect of MElatonin on Depression, Anxiety, CIrcadian and Sleep disturbances in patients after acute myocardial syndrome | ||||||||||||||||||||||||||||
Medical condition: Depression Anxiety Sleep disturbances Circadian disturbances | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-004005-11 | Sponsor Protocol Number: ESKETINTRD2003 | Start Date*: 2013-12-17 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: A Double-Blind, Doubly-Randomized, Placebo-Controlled Study of Intranasal Esketamine in an Adaptive Treatment Protocol to Assess Safety and Efficacy in Treatment-Resistant Depression (SYNAPSE) | |||||||||||||
Medical condition: Treatment Resistant Major Depression | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003867-13 | Sponsor Protocol Number: CL2-47445-014 | Start Date*: 2016-02-15 | |||||||||||
Sponsor Name:Institut de Recherches internationales Servier | |||||||||||||
Full Title: Efficacy and safety of S 47445 versus placebo as adjunctive treatment of Major Depressive Disorder in patients with an inadequate response to antidepressant therapy. A randomised, double-blind, pla... | |||||||||||||
Medical condition: Major depressive disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) FI (Completed) SK (Completed) CZ (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004147-33 | Sponsor Protocol Number: EFC5895 | Start Date*: 2007-02-21 |
Sponsor Name:sanofi-aventis recherche & développement | ||
Full Title: An Eight-Week, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Fixed Dose of SR58611A 350 mg Twice a Day in Elderly Patients with Generalized ... | ||
Medical condition: Generalized Anxiety Disorder | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Prematurely Ended) AT (Prematurely Ended) SK (Completed) | ||
Trial results: View results |
EudraCT Number: 2022-001997-70 | Sponsor Protocol Number: EXCELLENCE/0421/0543v1 | Start Date*: 2022-11-16 | ||||||||||||||||||||||||||
Sponsor Name:University of Cyprus | ||||||||||||||||||||||||||||
Full Title: Efficacy of Ketamine for the Prevention of Relapse in Patients with Opioid-Use Disorders (OUD) | ||||||||||||||||||||||||||||
Medical condition: Methadone and buprenorphine comprise a first-line, evidence-based opioid substitution treatment (OST) for OUD patients. Unfortunately, retention and adherence to OST treatment is currently a major ... | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: CY (Trial now transitioned) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
